Around $467M Bet On Occidental Petroleum? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mixed on Wednesday, there were a few notable insider trades.
Nocera And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Multimillionaire Twitter Philanthropist Offers Huge Reward For Whistleblower In SVB Bank Collapse
Detroit-based multi-millionaire and former director of PulteGroup, Inc. (NYSE: PHM) Bill Pulte has garnered a reputation on social media, specifically Twitter, for being a philanthropist, doling out thousands of dollars via tweets to his followers.
SVB Financial CEO Sold $3.6M In Shares Prior To Bank’s Collapse: Here Are Other Insider Sellers
One of the biggest financial stories of the week was the collapse of SVB Financial Group (NASDAQ: SIVB) as the company's share price fell significant throughout the later portion of the week.
Over $395M Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones closed lower on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Asana CEO Plans To Purchase Up To 30M Stock Under Trading Plan, Shares Soar
On March 8, 2023, Asana, Inc (NYSE:ASAN) Chair and CEO Dustin Moskovitz shared plans to purchase up to 30 million…
Why Cassava Sciences Stock Is Surging After Hours
Cassava Sciences Inc (NASDAQ: SAVA) shares are rising in extended trading Wednesday in the wake of recent insider buying.
Ambrx Biopharma 13D Filing Shows Darwin Global Management, Ltd. Increased Stake In Co To 26.4%
- 13D Filing
SEC Form 4
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a)